Tinea capitis is a common superficial fungal infection in China. Its atypical clinical manifestations often lead to misdiagnosis as other scalp conditions, resulting in inappropriate treatment and potentially scarring alopecia, which severely impacts patients’ quality of life and mental health. Studies indicate that among pediatric tinea capitis patients in China, males predominate (56.2%), often with a history of animal contact (57.4%), and the primary causative agent is zoophilic dermatophyte (73.5%). Adult tinea capitis patients are predominantly female (83.3%), often with prior fungal infections elsewhere on the body, with dermatophytes of human affinity being the primary causative agent (53.5%). The most common pathogen in China is the zoophilic Microsporum canis (65.2%), primarily distributed in eastern, western, and northeastern regions; followed by dermatophyte-like Trichophyton rubrum (13.6%), predominantly distributed in central regions [1]. Given pathogen variations across age groups, genders, and geographic areas, establishing rapid and precise diagnostic protocols holds critical clinical significance for personalized treatment. Therefore, in reviewing various auxiliary tests, this paper will focus on analyzing their capabilities in bacterial species identification and their significance in guiding treatment selection.

Traditional auxiliary tests for tinea capitis—including Wood’s lamp examination, microscopic fungal examination, and fungal culture—have been continuously optimized in recent years. Using Wood’s lamp and dermatoscopy to determine sampling sites and select appropriate fluorescent dyes can enhance the positive rate of microscopic examination. Combining molecular diagnostic techniques can shorten the identification time for fungal cultures. However, when faced with atypical clinical presentations and the need for rapid diagnosis, traditional methods still have limitations in sensitivity and timeliness. This has driven extensive research and the application of more efficient and precise new technologies. Dermoscopy provides crucial evidence for tinea capitis diagnosis by identifying characteristic hair shaft alterations such as “comma hair” and “spiral hair”. Reflectance confocal microscopy (RCM) enables real-time observation of fungal structures at the cellular level, offering a “non-invasive biopsy” for differentiating tinea capitis from other scalp conditions. Molecular diagnostic techniques enable rapid, highly sensitive pathogen identification and typing, significantly aiding timely tinea capitis diagnosis. Despite the promising prospects of these new technologies, their high costs and lack of standardization remain major obstacles to clinical adoption, requiring a balance between diagnostic value and health economic benefits. This article summarizes auxiliary diagnostic methods for tinea capitis—from traditional to cutting-edge approaches—along with their research progress.

Robert Williams Wood invented the Wood’s lamp for ultraviolet photography. Its ability to induce fluorescence in specific substances later led to widespread medical applications. Dermatophytes produce and accumulate specific fluorescent substances during growth and metabolism within hair shafts. Consequently, tinea capitis caused by different pathogens often exhibits distinct fluorescent colors under Wood’s lamp. With evolving prevalent pathogens and deeper observations, the spectrum of fluorescent colors associated with various pathogens has significantly broadened beyond traditional understanding, marking the evolution of the Wood’s lamp toward a multi-spectral fluorescence mode.

Recent studies have reported that infections caused by Trichophyton rubrum may exhibit pale blue, dark blue, or dark gray-green fluorescence; infections caused by Microsporumcanis, Trichophyton rubrum, and Trichophytonaudouinii may show blue-green, bright green, or yellow-green fluorescence; while infections with Trichophytonviolaceum and Trichophyton rubrum show no fluorescence [2]-[5].

In a study of 73 patients, Johansen et al. found that Wood’s lamp had 100% sensitivity, 86% specificity, 100% negative predictive value, and 53% positive predictive value. Thus, a negative result cannot rule out tinea capitis, requiring further mycological examination for definitive diagnosis. Given that Trichophyton rubrum is currently one of the common pathogens in China, its lack of fluorescence under Wood’s lamp has led to a decrease in the overall sensitivity of Wood’s lamp compared to previous studies. Johansen et al. also noted that Wood’s lamp can assist physicians in accurately locating sampling areas, and combining it with fungal microscopy or fungal culture can improve the positive detection rate [6]. Jing Zeng et al. found that in assessing treatment efficacy, fluorescence disappearance under Wood’s lamp occurred earlier than negative fungal microscopy results, suggesting potential superior sensitivity for evaluating treatment response. However, limited data currently exist to support this, and fluorescence disappearance cannot yet be considered a cure marker; definitive diagnosis still requires fungal examination [7].

Therefore, Wood’s lamp is currently primarily used for rapid screening of tinea capitis and for guiding specimen collection for fungal fluorescence microscopy. Its dynamic fluorescence changes may offer new insights for future exploration of non-invasive efficacy monitoring indicators, but further studies are needed to validate its reliability. However, the Wood lamp cannot distinguish specific bacterial species, and its screening value is limited by the fluorescent characteristics of prevalent bacteria in the region.

Histopathology involves microscopic examination of fungal morphology and distribution within scalp biopsy specimens. While long regarded as the morphological “gold standard” for diagnosing tinea capitis, its invasive nature limits routine use, reserving it primarily for confirming challenging cases.

Histopathology does not always directly reveal fungal elements, sometimes presenting solely as folliculitis. Elmas et al. found that fungal elements are difficult to observe in histopathological examinations of pyruvata infections, likely due to dense inflammatory infiltration obscuring the pathogens. Guiding biopsy site selection with dermatoscopy—specifically, seeking characteristic dermatoscopic features like “comma hair” at the periphery of inflammatory areas—significantly improves fungal detection rates. Additionally, observing the autofluorescence of fungal components under fluorescence microscopy on periodic acid-Schiff (PAS)-stained sections offers a novel technical approach to enhance detection rates [14].

Traditional histopathology may not reliably distinguish all fungal species. When species identification is uncertain, polymerase chain reaction (PCR) and in situ hybridization can supplement diagnosis [14]. Eckert et al. found that PCR targeting the fungal ITS2 region demonstrated significantly higher sensitivity (95%) in tissue sections compared to conventional PAS staining (74%) [15].

Therefore, histopathology has evolved from a static “gold standard” into a dynamic, integrated diagnostic analysis node. Through integration with molecular techniques, it not only confirms tinea capitis but also enables in situ fungal species identification within tissue samples. Future efforts will focus on addressing clinical challenges, such as diagnosing severe inflammatory tinea capitis and differentiating deep fungal infections.

Methods such as Wood’s lamp examination, fungal fluorescence microscopy, and fungal culture each have distinct limitations, driving the development of molecular diagnostic technologies with higher sensitivity, specificity, and speed. Molecular diagnostics centered on nucleic acid amplification and sequencing have propelled tinea capitis diagnosis from reliance on phenotypic observation into an era of precision based on genotypic identification. The most prevalent molecular diagnostic techniques currently include various PCR methods and MALDI-TOF MS.

Conventional PCR employs universal primers to amplify the fungal rDNA ITS region followed by sequencing. However, this method demands high template DNA quality and quantity while being prone to non-specific binding. Nested PCR represents an improvement over conventional PCR, primarily involving secondary amplification of fragments amplified by conventional PCR. This reduces non-specific binding of the initial PCR products, enhancing specificity and sensitivity. However, the secondary amplification process carries a higher risk of contamination and prolongs diagnostic time [23]. Multiplex PCR enables simultaneous detection of multiple targets within a single reaction, completing the process from DNA extraction to result interpretation within hours. It is suitable for scenarios such as negative mycological test results, contaminated cultures, and clinical mixed infections. However, a drawback is that primers may form dimers, potentially affecting results [9]. Real-time PCR employs specific probes to minimize contamination risks, eliminating the need for post-PCR detection and gel electrophoresis analysis. It also provides quantitative data on microbial load in samples, facilitating disease severity assessment. Sebastian et al. demonstrated that real-time PCR achieves an identification rate of 82.9% for dermatophytes [24].

MALDI-TOF MS identifies fungi by analyzing fingerprint spectra of protein extracts. It should be clarified that MALDI-TOF MS is typically used for rapid identification of pure colonies obtained from culture, rather than for direct detection of clinical specimens. This positions it in the diagnostic workflow after the culture step. Sebastian et al. reported a dermatophyte identification rate of 97.2% for MALDI-TOF MS [24]. Current limitations of MALDI-TOF MS primarily stem from insufficient representation of dermatophyte species in the reference spectral library of the identification system, coupled with the lack of a comprehensive database for rapid consultation [9]. Future research is needed to expand the reference spectral library.

While the aforementioned molecular diagnostic techniques significantly enhance the sensitivity, specificity, and timeliness of tinea capitis diagnosis, their drawback lies in demanding high laboratory standards, making widespread adoption in primary care hospitals challenging. Extending molecular testing beyond laboratories to primary care settings is crucial for improving diagnostic accessibility, a gap effectively addressed by isothermal amplification technology. Isothermal amplification techniques enable nucleic acid amplification using portable devices at constant temperatures, yielding results within 30 - 60 minutes. Examples include recombinase polymerase amplification (RPA) and loop-mediated isothermal amplification (LAMP). Currently, loop-mediated isothermal amplification (LAMP) kits targeting specific pathogens such as Trichophyton rubrum and Candida species are available. Developing point-of-care isothermal amplification detection kits for common pathogens that cause tinea capitis is a key direction for advancing molecular diagnostics at the primary care level.

Although molecular diagnostics carry higher costs, from a health economics perspective, they may offer long-term cost-effectiveness advantages by enabling rapid and precise pathogen identification. This approach helps prevent prolonged illness, recurrence, transmission, and additional medical expenses resulting from misdiagnosis or inappropriate empirical treatment.

This systematic review of research progress in auxiliary tests for tinea capitis nevertheless has certain limitations. First, the cited studies may exhibit publication bias. Second, the review primarily references data from Chinese populations, meaning conclusions may be more applicable to regions with similar epidemiological contexts, and their global applicability requires further validation. Future work necessitates more multicenter, large-sample prospective studies to validate and optimize the diagnostic strategies proposed herein.

Based on the advantages and limitations of the aforementioned techniques, we propose a preliminary tiered diagnostic workflow for clinical application as a reference: 1) For patients suspected of having tinea capitis, prioritize rapid screening with Wood’s lamp to guide specimen collection; 2) Combine with dermatoscopy to identify characteristic hair changes, and perform fungal fluorescent microscopy on active lesions to achieve rapid diagnosis; 3) If fungal microscopy is positive but clinical presentation is atypical, treatment response is poor, or precise medication is required, proceed with fungal culture; 4) Following positive culture, select MALDI-TOF MS or PCR sequencing for species identification based on laboratory capabilities; 5) For challenging cases with severe inflammation or diagnostic uncertainty, consider dermoscopy-guided biopsy for histopathological examination combined with molecular techniques like PCR for identification; 6) Utilize RCM as a complementary tool for non-invasive differential diagnosis and treatment monitoring. This workflow aims to balance diagnostic speed, accuracy, and cost to achieve personalized diagnosis and treatment.

In summary, tinea capitis diagnosis has evolved from reliance on clinical experience and single tests to a tiered, efficient diagnostic system combining multiple techniques. Wood’s lamp sensitivity remains unsatisfactory and is generally used only as a rapid screening tool. Fluorescent microscopy, guided by Wood’s lamp or dermatoscopy to optimize sampling sites, improves fungal positivity rates and serves as a common rapid clinical diagnostic method. Combining fungal culture with molecular diagnostics shortens identification time but remains limited by high laboratory requirements. Dermoscopy and RCM enable non-invasive microscopic examination, yet standardized diagnostic criteria supported by sufficient data remain lacking. Molecular diagnostics achieve rapid, precise pathogen identification and resolution of mixed infections, but high costs limit their adoption. Future research should focus on: 1) Developing AI-assisted automated dermatoscopic image recognition systems to enhance diagnostic objectivity and efficiency; 2) Expanding dermatophyte protein profiling databases using technologies like MALDI-TOF MS to improve species identification coverage; 3) Developing low-cost, portable point-of-care isothermal amplification devices for common scalp ringworm pathogens to advance molecular diagnostics at primary care levels; 4) Conducting cost-effectiveness studies grounded in health economics to provide evidence-based support for optimizing diagnostic strategies across healthcare tiers. Through technological innovation and process optimization, a more accessible and precise diagnostic system for scalp ringworm can be established.

Conceptualization: Faqing Huang; Writing—original draft preparation: Qianqian Wu; Manuscript critical revision: Shan Su; Writing—review and editing: Faqing Huang; Supervision: Faqing Huang.

*Corresponding author.